NO20012612L - Isonipecotamider for behandlingen av integrin-formidlede sykdommer - Google Patents
Isonipecotamider for behandlingen av integrin-formidlede sykdommerInfo
- Publication number
- NO20012612L NO20012612L NO20012612A NO20012612A NO20012612L NO 20012612 L NO20012612 L NO 20012612L NO 20012612 A NO20012612 A NO 20012612A NO 20012612 A NO20012612 A NO 20012612A NO 20012612 L NO20012612 L NO 20012612L
- Authority
- NO
- Norway
- Prior art keywords
- isonipecotamides
- integrin
- treatment
- mediated diseases
- mediated
- Prior art date
Links
- DPBWFNDFMCCGGJ-UHFFFAOYSA-N 4-Piperidine carboxamide Chemical class NC(=O)C1CCNCC1 DPBWFNDFMCCGGJ-UHFFFAOYSA-N 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 102000006495 integrins Human genes 0.000 title 1
- 108010044426 integrins Proteins 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15661799P | 1999-09-29 | 1999-09-29 | |
US66713400A | 2000-09-21 | 2000-09-21 | |
PCT/US2000/026163 WO2001023376A1 (en) | 1999-09-29 | 2000-09-22 | Isonipecotamides for the treatment of integrin-mediated disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20012612D0 NO20012612D0 (no) | 2001-05-28 |
NO20012612L true NO20012612L (no) | 2001-07-17 |
Family
ID=26853350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20012612A NO20012612L (no) | 1999-09-29 | 2001-05-28 | Isonipecotamider for behandlingen av integrin-formidlede sykdommer |
Country Status (18)
Country | Link |
---|---|
US (1) | US7718673B2 (de) |
EP (1) | EP1133489B9 (de) |
CN (1) | CN1352641A (de) |
AR (1) | AR034098A1 (de) |
AT (1) | ATE300531T1 (de) |
AU (1) | AU7711000A (de) |
BR (1) | BR0007183A (de) |
CA (1) | CA2352957A1 (de) |
CZ (1) | CZ20011872A3 (de) |
DE (2) | DE60021521T4 (de) |
ES (1) | ES2244474T3 (de) |
HU (1) | HUP0200439A2 (de) |
NO (1) | NO20012612L (de) |
NZ (1) | NZ511997A (de) |
PL (1) | PL347976A1 (de) |
RU (1) | RU2001114518A (de) |
WO (1) | WO2001023376A1 (de) |
YU (1) | YU22802A (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU662309B2 (en) | 1990-11-19 | 1995-08-31 | Monsanto Company | Retroviral protease inhibitors |
US7691843B2 (en) | 2002-07-11 | 2010-04-06 | Pfizer Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
US20040224986A1 (en) | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
ES2411965T3 (es) | 2004-04-02 | 2013-07-09 | The Regents Of The University Of California | Métodos y composiciones para tratar y prevenir enfermedad asociada con integrina alfa V beta 5 |
CA2724435A1 (en) | 2008-05-16 | 2009-11-19 | Allergan, Inc. | Selective subtype alpha 2 adrenergic agents and methods for use thereof |
US10087252B2 (en) | 2009-07-24 | 2018-10-02 | The Regents Of The University Of California | Methods and compositions for treating and preventing disease associated with αvβ5 integrin |
CN110291082A (zh) * | 2017-01-09 | 2019-09-27 | 阿德利克斯股份有限公司 | Nhe介导的反向转运的抑制剂 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2830555A1 (de) | 1978-07-12 | 1980-03-06 | Bayer Ag | Chinazolinonyl-verbindungen |
GB8829296D0 (en) | 1988-12-15 | 1989-01-25 | Ici Plc | Anti-tumour compounds |
JPH04334357A (ja) * | 1991-05-02 | 1992-11-20 | Fujirebio Inc | 酵素阻害作用を有するアシル誘導体 |
WO1993009795A1 (en) | 1991-11-22 | 1993-05-27 | Yeda Research And Development Co. Ltd. | Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them |
DE4208051A1 (de) * | 1992-03-13 | 1993-09-16 | Bayer Ag | Substituierte phenylessigsaeureamide |
US5648368A (en) * | 1992-12-01 | 1997-07-15 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US6268380B1 (en) | 1993-02-19 | 2001-07-31 | G. D. Searle & Co. | Urea derivatives useful as platelet aggregation inhibitors |
DE4309867A1 (de) * | 1993-03-26 | 1994-09-29 | Cassella Ag | Neue Harnstoffderivate, ihre Herstellung und Verwendung |
GB9313268D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Chemical compounds |
WO1995008536A1 (en) | 1993-09-22 | 1995-03-30 | Fujisawa Pharmaceutical Co., Ltd. | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
CA2190870A1 (en) | 1994-05-27 | 1995-12-07 | George D. Hartman | Compounds for inhibiting osteoclast-mediated bone resorption |
US5700801A (en) * | 1994-12-23 | 1997-12-23 | Karl Thomae, Gmbh | Piperazine derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
PL321003A1 (en) * | 1994-12-23 | 1997-11-24 | Thomae Gmbh Dr K | Derivatives of piperasine, drugs containing them, their application and methods of obtaining them |
US5602155A (en) * | 1995-01-17 | 1997-02-11 | G. D. Searle & Co. | Platelet aggregation inhibitors |
CA2754102C (en) | 1995-08-14 | 2012-12-18 | The Scripps Research Institute | Monoclonal antibodies and compositions comprising such useful for inhibition of .alpha.v.beta.5 mediated angiogenesis |
NZ318926A (en) | 1995-08-30 | 1999-04-29 | Searle & Co | Alpha v beta 3 integrin (vitronectin) inhibitors or anatagonists derived from benzoic acid for treating diseases of cell adhesion |
US6100423A (en) * | 1995-08-30 | 2000-08-08 | G. D. Searle & Co. | Amino benzenepropanoic acid compounds and derivatives thereof |
EP0858457A1 (de) * | 1995-10-20 | 1998-08-19 | Dr. Karl Thomae GmbH | 5-gliedrige heterocyclen, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung |
DE19548709A1 (de) | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosinderivate |
EP0891325B1 (de) | 1996-03-29 | 2002-02-06 | G.D. Searle & Co. | Para-substituierte phenylpropansäure derivate als integrin-antagonisten |
DE69739239D1 (de) * | 1996-05-01 | 2009-03-19 | Ortho Mcneil Pharm Inc | Carboxamidderivate von Pyrrolidin, Piperidin und Hexahydropiperizin für Behandlung von Thrombosen |
DE19642591A1 (de) | 1996-10-15 | 1998-04-16 | Basf Ag | Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung |
JP3841898B2 (ja) * | 1996-11-21 | 2006-11-08 | 三菱電機株式会社 | 深部線量測定装置 |
WO1998025892A1 (en) | 1996-12-09 | 1998-06-18 | Eli Lilly And Company | Integrin antagonists |
AR011913A1 (es) | 1997-03-06 | 2000-09-13 | Yamano Masaki | Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos. |
WO1999016758A1 (en) | 1997-10-27 | 1999-04-08 | Dr. Reddy's Research Foundation | Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
US6066651A (en) | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
AU1415099A (en) | 1997-11-18 | 1999-06-07 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
WO1999050249A2 (en) | 1998-04-01 | 1999-10-07 | Du Pont Pharmaceuticals Company | Pyrimidines and triazines as integrin antagonists |
EP1077941B1 (de) | 1998-05-11 | 2009-08-12 | Novo Nordisk A/S | Verbindungen mit wachstumshormon freisetzenden eigenschaften |
TW591026B (en) * | 1998-06-23 | 2004-06-11 | Upjohn Co | Inhibitors of alpha4beta1 mediated cell adhesion |
US6388054B1 (en) | 1998-08-20 | 2002-05-14 | John M. Stewart | Anti-cancer compounds |
AU2164300A (en) | 1998-12-04 | 2000-06-26 | N.V. Organon | Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin |
WO2001010867A1 (en) | 1999-08-06 | 2001-02-15 | Smithkline Beecham Corporation | Vitronectin receptor antagonists useful for the treatment of strokes |
WO2001011002A1 (en) | 1999-08-10 | 2001-02-15 | The Procter And Gamble Company | Nonaqueous liquid detergent with wash-water soluble low-density filler particles |
-
2000
- 2000-09-22 NZ NZ511997A patent/NZ511997A/xx unknown
- 2000-09-22 PL PL00347976A patent/PL347976A1/xx not_active Application Discontinuation
- 2000-09-22 BR BR0007183-8A patent/BR0007183A/pt not_active IP Right Cessation
- 2000-09-22 CN CN00803033A patent/CN1352641A/zh active Pending
- 2000-09-22 WO PCT/US2000/026163 patent/WO2001023376A1/en active IP Right Grant
- 2000-09-22 AT AT00966823T patent/ATE300531T1/de not_active IP Right Cessation
- 2000-09-22 RU RU2001114518/04A patent/RU2001114518A/ru not_active Application Discontinuation
- 2000-09-22 ES ES00966823T patent/ES2244474T3/es not_active Expired - Lifetime
- 2000-09-22 AU AU77110/00A patent/AU7711000A/en not_active Abandoned
- 2000-09-22 CA CA002352957A patent/CA2352957A1/en not_active Abandoned
- 2000-09-22 DE DE60021521T patent/DE60021521T4/de not_active Expired - Lifetime
- 2000-09-22 EP EP00966823A patent/EP1133489B9/de not_active Expired - Lifetime
- 2000-09-22 CZ CZ20011872A patent/CZ20011872A3/cs unknown
- 2000-09-22 DE DE60021521A patent/DE60021521D1/de not_active Expired - Fee Related
- 2000-09-22 HU HU0200439A patent/HUP0200439A2/hu unknown
- 2000-09-28 AR ARP000105121A patent/AR034098A1/es unknown
- 2000-09-29 YU YU22802A patent/YU22802A/sh unknown
-
2001
- 2001-05-28 NO NO20012612A patent/NO20012612L/no not_active Application Discontinuation
-
2003
- 2003-01-16 US US10/345,808 patent/US7718673B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60021521D1 (de) | 2005-09-01 |
NZ511997A (en) | 2004-12-24 |
BR0007183A (pt) | 2002-02-05 |
EP1133489B9 (de) | 2006-05-03 |
AR034098A1 (es) | 2004-02-04 |
EP1133489A1 (de) | 2001-09-19 |
CZ20011872A3 (cs) | 2002-03-13 |
NO20012612D0 (no) | 2001-05-28 |
AU7711000A (en) | 2001-04-30 |
HUP0200439A2 (en) | 2002-06-29 |
PL347976A1 (en) | 2002-05-06 |
US7718673B2 (en) | 2010-05-18 |
CA2352957A1 (en) | 2001-04-05 |
DE60021521T4 (de) | 2006-09-21 |
CN1352641A (zh) | 2002-06-05 |
ATE300531T1 (de) | 2005-08-15 |
EP1133489B1 (de) | 2005-07-27 |
WO2001023376A1 (en) | 2001-04-05 |
DE60021521T2 (de) | 2006-06-08 |
RU2001114518A (ru) | 2003-04-20 |
YU22802A (sh) | 2005-06-10 |
US20030181440A1 (en) | 2003-09-25 |
ES2244474T3 (es) | 2005-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20014379L (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
NO20012995L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
NO20013380D0 (no) | 2-aminobenzoksazinonderivater for behandling av fedme | |
NO995221D0 (no) | Sulfonamider for behandling av endotelinmedierte sykdommer | |
NO20031442L (no) | Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
NO20022087L (no) | Fremgangsmåte for behandling av diabetes | |
NO20031443D0 (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
NO20013381D0 (no) | 2-oksybenzoksazinonderivater for behandling av fedme | |
NO20026008L (no) | Fremgangsmåte for behandling av cardiovaskul¶re sykdommer | |
NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
NO20013507L (no) | Blandinger for behandling av inflammatoriske reaksjoner | |
NO20010953D0 (no) | En fremgangsmÕte for behandling av stafylokokkal sykdom | |
NO20024776D0 (no) | Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte | |
NO20024777D0 (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
ID26097A (id) | Proses pembuatan pakaian luar sekali pakai | |
NO20020784L (no) | Medikament for behandling av brudd | |
NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
NO20042476L (no) | Anvendelse av desoxypeganin for behandling av klinisk depresjon | |
PT1200447E (pt) | Oxazinocarbazoles para o tratamento de doencas do snc | |
NO20002481D0 (no) | Kombinasjonsterapi for behandling av AIDS | |
NO20033290L (no) | Pyrrolderivater for behandling av cytokinformidlede sykdommer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |